STRATA Skin Sciences (SSKN) Short term Debt (2013 - 2025)

STRATA Skin Sciences' (SSKN) quarterly Short term Debt came in at $15.3 million in Q4 2025, up 718.61% quarter-over-quarter from $1.9 million in Q3 2025.

STRATA Skin Sciences (SSKN) Short term Debt (2013 - 2025) Analysis & Trends

STRATA Skin Sciences has disclosed Short term Debt across 10 years of filings, most recently posting $15.3 million for Q4 2025.

  • Short term Debt for Q4 2025 came in at $15.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $15.3 million (changed N/A YoY), and the FY2025 annual result was $15.3 million, changed N/A from the prior year.
  • Short term Debt came in at $15.3 million for Q4 2025 at STRATA Skin Sciences, up from $1.9 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $15.3 million in Q4 2025 to a low of $3000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 STRATA Skin Sciences - - 5.61 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 15.35 Mn
Sep 30, 2025 1.88 Mn
Jun 30, 2021 3,000.00
Mar 31, 2021 1.81 Mn
Dec 31, 2020 1.48 Mn
Sep 30, 2020 1.13 Mn
Jun 30, 2020 799,000.00
Sep 30, 2019 2.52 Mn
Jun 30, 2019 1.77 Mn
Mar 31, 2019 1.01 Mn
Dec 31, 2018 252,000.00
Sep 30, 2018 726,000.00
Mar 31, 2018 3.41 Mn
Dec 31, 2017 2.39 Mn
Sep 30, 2017 1.94 Mn
Jun 30, 2017 3.43 Mn
Mar 31, 2017 2.57 Mn
Dec 31, 2016 1.71 Mn
Sep 30, 2016 857,000.00
Sep 30, 2015 8.85 Mn